220 related articles for article (PubMed ID: 16719916)
21. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the human CIDEA promoter in fat cells.
Pettersson AT; Laurencikiene J; Nordström EA; Stenson BM; van Harmelen V; Murphy C; Dahlman I; Rydén M
Int J Obes (Lond); 2008 Sep; 32(9):1380-7. PubMed ID: 18607384
[TBL] [Abstract][Full Text] [Related]
23. Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells.
Lind H; Haugen A; Zienolddiny S
Cytokine; 2007 Apr; 38(1):43-8. PubMed ID: 17587593
[TBL] [Abstract][Full Text] [Related]
24. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor.
Wunsch A; Ahda Y; Banaz-Yaşar F; Sonntag B; Nieschlag E; Simoni M; Gromoll J
Fertil Steril; 2005 Aug; 84(2):446-53. PubMed ID: 16084888
[TBL] [Abstract][Full Text] [Related]
25. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the human PRIP-1 gene structure and transcriptional regulation.
Murakami A; Matsuda M; Nakasima A; Hirata M
Gene; 2006 Nov; 382():129-39. PubMed ID: 16952428
[TBL] [Abstract][Full Text] [Related]
27. Four novel single nucleotide polymorphisms within the promoter region of p53 gene and their associations with uterine leiomyoma.
Hsieh YY; Wang JP; Lin CS
Mol Reprod Dev; 2007 Jul; 74(7):815-20. PubMed ID: 17186536
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes-associated fatty acid binding protein 2 promoter haplotypes are differentially regulated by GATA factors.
Klapper M; Böhme M; Nitz I; Döring F
Hum Mutat; 2008 Jan; 29(1):142-9. PubMed ID: 17960769
[TBL] [Abstract][Full Text] [Related]
29. Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors.
Siegling S; Thyzel E; Glahn J; Kleesiek K; Götting C
Ann Hematol; 2006 Jan; 85(1):32-7. PubMed ID: 16247609
[TBL] [Abstract][Full Text] [Related]
30. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
[TBL] [Abstract][Full Text] [Related]
31. No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity.
Kereszturi E; Kiraly O; Barta C; Molnar N; Sasvari-Szekely M; Csapo Z
BMC Mol Biol; 2006 May; 7():18. PubMed ID: 16723017
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
[TBL] [Abstract][Full Text] [Related]
33. Functional characterization of the regulatory region of human CD2-associated protein promoter in HEK 293 cells.
Su XM; Ren W; Lu C; Chen JQ; Wu SH; Chen RH; Zhou GP
Am J Nephrol; 2009; 29(3):203-12. PubMed ID: 18791326
[TBL] [Abstract][Full Text] [Related]
34. Suppression of thymidine phosphorylase expression by promoter methylation in human cancer cells lacking enzyme activity.
Guarcello V; Blanquicett C; Naguib FN; El Kouni MH
Cancer Chemother Pharmacol; 2008 Jun; 62(1):85-96. PubMed ID: 17805539
[TBL] [Abstract][Full Text] [Related]
35. Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation.
Lira MG; Mazzola S; Tessari G; Malerba G; Ortombina M; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Girolomoni G; Turco A
Br J Dermatol; 2007 Jul; 157(1):49-57. PubMed ID: 17578436
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide analysis of factors regulating gene expression in liver.
Teufel A; Weinmann A; Krupp M; Budinger M; Galle PR
Gene; 2007 Mar; 389(2):114-21. PubMed ID: 17174484
[TBL] [Abstract][Full Text] [Related]
37. Strong bias in the location of functional promoter polymorphisms.
Buckland PR; Hoogendoorn B; Coleman SL; Guy CA; Smith SK; O'Donovan MC
Hum Mutat; 2005 Sep; 26(3):214-23. PubMed ID: 16086313
[TBL] [Abstract][Full Text] [Related]
38. Two SNPs in the promoter region of the CTLA-4 gene affect binding of transcription factors and are associated with human myasthenia gravis.
Wang XB; Pirskanen R; Giscombe R; Lefvert AK
J Intern Med; 2008 Jan; 263(1):61-9. PubMed ID: 18088253
[TBL] [Abstract][Full Text] [Related]
39. Identification of the minimal promoter region of the mouse NKX5-3, a transcription factor implicated in eye development.
Nichini O; Schorderet DF
Gene; 2008 Mar; 411(1-2):10-8. PubMed ID: 18258389
[TBL] [Abstract][Full Text] [Related]
40. Hunchback sequence binding protein suppresses mouse TGF-beta3 promoter in vitro.
Yamazaki K; Crowe DL; Shuler CF
Biochem Biophys Res Commun; 2006 Aug; 346(3):802-9. PubMed ID: 16781676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
